The Surrey Clinical Research Centre has the in-house expertise to assist you in the successful design and execution of vaccine clinical trials ranging from Phase I FIH through to Phase IV.

We offer a highly skilled team of staff who are experts in planning and undertaking clinical trials aligned with specialised scientific expertise in clinical vaccinology.

Our external Principal Investigator Professor David Lewis is specialised in infectious diseases and tropical medicine, with specific expertise in mucosal immunology, mucosal vaccine delivery, and live genetically modified vaccines. He is on a NRES GTAC gene therapy advisory committee. He has been Principal Investigator or Chief Investigator of numerous parenteral and mucosal vaccine trials, including first-use in humans of GM live attenuated vaccines.

For further information please contact: crc-businessdevelopment@surrey.ac.uk